| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2006;30:28-32
© 2006 Elsevier Science NL
a Department of Cardio-thoracic Surgery, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 EZ Groningen, The Netherlands
b Department of Cardiology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 EZ Groningen, The Netherlands
Received 25 September 2005; received in revised form 11 February 2006; accepted 13 February 2006.
* Corresponding author. Address: UMCG, University of Groningen, Postbus 30.001, 9700 RB Groningen, The Netherlands. Tel.: +31 50 3613238; fax: +31 50 3611347. (Email: t.w.waterbolk{at}thorax.umcg.nl).
Objective: Pulmonary valve replacement is performed increasingly late after correction of Tetralogy of Fallot. Most reports deal with pulmonary allografts as the valvar substitute of choice, although late deterioration and reoperation(s) are the rule. Mechanical valves are scarcely reported and if so only because of complications. Although life-long anticoagulation therapy is indicated for mechanical prostheses, the chance of subsequent re-operations can be expected to be low. We report the results of 28 mechanical valve replacements in the pulmonary position. Methods: A mechanical valve was implanted in 27 of 79 patients indicated for pulmonary valve replacement. Tetralogy of Fallot was the most common basic lesion. The results and follow-up were reviewed retrospectively, where death and re-operation were primary end points. Routine outpatient follow-up, including trans-thoracic echocardiography, was performed. Results: Twenty-eight pulmonary valve implantations were done in 27 patients. Thirty-day hospital mortality was 1/28 (3.6%), because of a cerebro-vascular accident. One patient died late (2.8 years postoperatively). Median age was 33 years and the median interval between primary repair and insertion of the prosthesis was 26 years. Freedom from re-operation at 1 year was 100%. One valve had to be replaced 14 years after implantation because of malfunction due to ingrowth of endomyocardial fibrosis. No thrombo-embolic events were observed. Conclusions: Our series do not confirm the bad reputation of mechanical valvar prostheses in the pulmonary position. On the contrary they perform well and result in a much lower re-operation rate than can be expected and in fact is reported after allograft usage. No thrombo-embolic complications were noted. In our experience pulmonary mechanical valve prostheses do well.
Key Words: Congenital heart disease • Pulmonary valve • Tetralogy of Fallot • Heart valve • Mechanical • Reoperation
This article has been cited by other articles:
|
|
 |
|
  J. Horer, M. Vogt, U. Stierle, J. Cleuziou, Z. Prodan, C. Schreiber, and R. Lange A comparative study of mechanical and homograft prostheses in the pulmonary position. Ann. Thorac. Surg., November 1, 2009; 88(5): 1534 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Messmer Invited commentary. Ann. Thorac. Surg., November 1, 2009; 88(5): 1539 - 1540. [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Bruce and H. M. Connolly Right-Sided Valve Disease Deserves a Little More Respect Circulation, May 26, 2009; 119(20): 2726 - 2734. [Full Text] [PDF]
|
|
|
|
 |
|
 M.G. Hazekamp Editorial comment A mechanical prosthesis for pulmonary valve replacement? Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 33 - 34. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
